Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease

Tetrahydro-1H-pyrazino[2,1-a]isoindolylquinoline compounds for the treatment of autoimmune disease

US Patent 12157746 · Granted Dec 3, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Triazatricycle compounds for the treatment of autoimmune disease2025
Triazatricycle compounds for the treatment of autoimmune disease2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Hydro-1H-pyrrolo[1,2-a]pyrazine compounds for the treatment of autoimmune diseas2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Hydropyrazino[1,2-d][1,4]diazepine compounds for the treatment of autoimmune dis2025
Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease2025
Dihydrobenzimidazolones for medical treatment2025